Endometrial Cancer Clinical Trials in Stockholm
3 recruitingStockholm, Sweden
Showing 1–3 of 3 trials
Recruiting
Phase 3
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
AstraZeneca600 enrolled249 locationsNCT06989112
Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Ovarian CancerCervical CancerEndometrial Cancer+6 more
Universitaire Ziekenhuizen KU Leuven200 enrolled4 locationsNCT05610501
Recruiting
Phase 2Phase 3
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Kartos Therapeutics, Inc.268 enrolled83 locationsNCT05797831